Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scleroderma, Localized”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Not applicableLooking for participantsNCT04095351
What this trial is testing

Connective Tissue Diseases and Lung Manifestations

Who this might be right for
Connective Tissue DiseasesInterstitial Lung DiseaseSystemic Sclerosis
Medical University Innsbruck 120
Not applicableStudy completedNCT01697254
What this trial is testing

The CARRA Registry

Who this might be right for
Juvenile Idiopathic ArthritisSystemic Lupus ErythematosusMixed Connective Tissue Disease+9 more
Duke University 9,587
Early research (Phase 1)WithdrawnNCT02680717
What this trial is testing

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

Who this might be right for
Scleroderma
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT00936546
What this trial is testing

A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy

Who this might be right for
Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
University Hospital, Ghent 3
Not applicableStudy completedNCT00001330
What this trial is testing

Study of Silicone-Associated Connective Tissue Diseases

Who this might be right for
Autoimmune DiseasesConnective Tissue DiseasesScleroderma, Circumscribed+1 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Testing effectiveness (Phase 2)Study completedNCT04200755
What this trial is testing

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma

Who this might be right for
Localized Scleroderma
University of Cologne 45
Not applicableEnrolling By InvitationNCT06847750
What this trial is testing

Elastography Ultrasound in Localized Scleroderma (Morphea) Study

Who this might be right for
Scleroderma
The Hospital for Sick Children 20
Not applicableStudy completedNCT00812188
What this trial is testing

Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

Who this might be right for
Symmetric Limited Morphea
University of Texas Southwestern Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00479934
What this trial is testing

Efficacy and Safety of Imatinib in Scleroderma

Who this might be right for
Scleroderma, LocalizedScleroderma, Systemic
University Hospital, Bordeaux 28
Very early researchEnded earlyNCT02411643
What this trial is testing

Molecular Effects of Topical Calcipotriene on Morphea

Who this might be right for
MorpheaLocalized Scleroderma
Northwestern University 2
Not applicableStudy completedNCT00476801
What this trial is testing

UVA1 Light for Treatment of Scleroderma and Similar Conditions

Who this might be right for
SclerodermaKeloidsOther Fibrosing Conditions
University of Michigan 27
Not applicableStudy completedNCT02222038
What this trial is testing

Genetic Variants in Linear Localized Scleroderma

Who this might be right for
Morphea
University Children's Hospital, Zurich 50
Not applicableActive Not RecruitingNCT06880627
What this trial is testing

Brain Boost Program to Improve Cognitive Function in People With Systemic Sclerosis

Who this might be right for
Scleroderma
University of Michigan 66
Not applicableStudy completedNCT01799174
What this trial is testing

Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea

Who this might be right for
Scleroderma, LocalizedMorpheaScleroderma, Circumscribed
University of Texas Southwestern Medical Center 14
Not applicableLooking for participantsNCT07182981
What this trial is testing

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Who this might be right for
Systemic Sclerosis (SSc)SclerodermaScleroderma (Limited and Diffuse)+2 more
Hacettepe University 50
Testing effectiveness (Phase 2)Ended earlyNCT03740724
What this trial is testing

FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea)

Who this might be right for
MorpheaScleroderma, LocalizedScleroderma
Castle Creek Biosciences, LLC. 1
Not applicableStudy completedNCT04752397
What this trial is testing

The Influence of Extracorporeal Photopheresis on Skin Sclerosis

Who this might be right for
Scleroderma, SystemicGraft Vs Host DiseaseEosinophilic Fasciitis+2 more
Charite University, Berlin, Germany 6
Not applicableActive Not RecruitingNCT04922736
What this trial is testing

Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases

Who this might be right for
Scleroderma, SystemicMorpheaGraft Vs Host Disease
University of Utah 30
Not applicableLooking for participantsNCT07292961
What this trial is testing

Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma

Who this might be right for
SclerodermaScleroderma, LocalizedScleroderma Systemic+4 more
Hacettepe University 48
Not applicableLooking for participantsNCT07183072
What this trial is testing

Patients Diagnosed With Scleroderma: Physical Performance and Functionality

Who this might be right for
Systemic Sclerosis (SSc)SclerodermaScleroderma (Limited and Diffuse)+2 more
Hacettepe University 50
Next Page